Clincosm LogoSign in Get a demo

The Impact Of Clinical Pharmacists Medication Reconciliation Upon Patients Admission To Reduce Medication Discrepancies.

Sponsor
Alexandria University (Other)
Overall Status
Completed
CT.gov ID
NCT04395443
Collaborator
(none)
161
Enrollment
1
Location
1
Arm
2.2
Actual Duration (Months)
74.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

It is a quazai one arm study shows the impact of the role of the clinical pharmacists through medication reconciliation to patients admitted to the emergency department .The main aim is to show if the pharmacists intervention is associated with establishing a complete drug history list than the list already presented in the patient file and taken by the physician .Then a description of the medication errors detected will be done .

Condition or Disease Intervention/Treatment Phase
  • Other: medication reconciliation
 N/A

Detailed Description

It is a quazai one arm study in which the pre phase is the detection of the complete and accurate drug history list already presented in the patient file and taken by the physician and the post phase is the detection of the complete and accurate drug history list taken by the clinical pharmacists after medication reconciliation for the same patients.

medication reconciliation will be done as a full diseases and preadmission medications history will be taken from the patients or the family through interviews, revising previous prescriptions and hospital records.

  • Preadmission medication history will include medications trade names, doses, frequency and route of administration and treatment duration and also will include the consumption of vitamins or herbs.

  • The medication errors will be detected ,calculated and classified according to medication at transitions and clinical handoffs (MATCH) toolkit for medication reconciliation.

Study Design

Study Type:
Interventional
Actual Enrollment :
161 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Comparative Prospective Interventional Study Shows The Impact Of The Clinical Pharmacists' Role In The Emergency Department In Medication Reconciliation Upon Patients' Admission To Reduce The Medication Discrepancies.
Actual Study Start Date :
Sep 25, 2020
Actual Primary Completion Date :
Nov 30, 2020
Actual Study Completion Date :
Nov 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: patients admitted to emergency department

the intervention is the medication reconciliation

Other: medication reconciliation
the emergency clinical pharmacists will start medication reconciliation with the admitted patients and a full diseases and preadmission medications history will be taken.A comparison between the accuracy and completeness of drug history lists already presented in the profile and drug history taken by the clinical pharmacists to detect the medication discrepancies

Outcome Measures

Primary Outcome Measures

  1. the total number of complete and accurate drug history list detected in each phase. [2 months]

    to calculate the total number of complete and accurate drug history list taken by the physicians and already presented in the profile (pre phase) and the total number of complete and accurate drug history list taken by the clinical pharmacists after medication reconciliation (post phase).

  2. Detect the number of medication discrepancies and the proportion of the prescriptions with one or more medication discrepancies [2 months]

    Calculate the total number of medication discrepancies detected after medication reconciliation and then calculate and the proportion of the prescriptions with one or more medication discrepancies from the total number of prescriptions. 2- to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation. 2- to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation. 2- to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation. to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation

  3. classification of medication discrepancies [2 months]

    to classify the medication discrepancies according to MATCH toolkit for medication reconciliation. 3- to calculate the proportion of the patients detected with one or more medication discrepancies 3- to calculate the proportion of the patients detected with one or more medication discrepancies 3- to calculate the proportion of the patients detected with one or more medication discrepancies to calculate the proportion of the patients detected with one or more medication discrepancies

  4. the total number of complete medication history lists will be written in the patients profiles [2 months]

    to calculate the total number of complete medication history lists will be written in the patients profiles by the clinical pharmacists after their interventions..

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with one or more chronic disease / drug.
Exclusion Criteria:
  • Patients who cannot communicate or have no family members.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alexandria Main University Hospital Alexandria Egypt

Sponsors and Collaborators

  • Alexandria University

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Heba Shaker, Supervisor of clinical pharmacy units in Alexandria Main University Hospital, Alexandria University
ClinicalTrials.gov Identifier:
NCT04395443
Other Study ID Numbers:
  • 0304494
First Posted:
May 20, 2020
Last Update Posted:
Dec 16, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Heba Shaker, Supervisor of clinical pharmacy units in Alexandria Main University Hospital, Alexandria University
Medication reconcilitation
Medication discrepancies
Admission pharmacist

Study Results

No Results Posted as of Dec 16, 2020